gdc

Follicular Lymphoma

FDA Approved Ukoniq, New Targeted Therapy, for Marginal-Zone and Follicular Lymphoma
FDA Approvals, News & UpdatesLymphomaFollicular Lymphoma
Ukoniq is the first dual inhibitor of PI3K-delta and CK1-epsilon to be approved by the FDA, and is the first targeted, once-daily oral therapy option for marginal-zone or follicular lymphoma.
Yescarta First Gene Therapy Approved for Follicular Lymphoma
FDA Approvals, News & UpdatesFollicular Lymphoma
Yescarta is the first CAR T-cell therapy approved by the FDA for patients with follicular lymphoma. It uses the patient’s own genetically modified T-cells to fight the cancer.
Enduring Spirit
Follicular LymphomaPatient Stories
With a demanding career and 3 small children, Pam Neff had to make some difficult decisions during her treatment for an aggressive blood cancer.
How Life Came Together After It Fell Apart with a Cancer Diagnosis
Follicular LymphomaPatient Stories
For Erika Brooks, it took some time to adjust to what it means to have an incurable cancer. She says, “at first, I kept thinking it was a death sentence.” Eventually, she came to see her cancer in a different light.
New Treatment Options for Patients with Follicular Lymphoma
Follicular Lymphoma
Several new treatment options were approved by the FDA for patients with follicular lymphoma.
Page 1 of 2
Results 1 - 10 of 12

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country